Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease. Murray A, Linn SM, Yu B, Novitzky-Basso I, et al. Bone Marrow Transplant 2024 Feb 24. doi: 10.1038/s41409-024-02249.

Read + Share

Amedeo Smart

Independent Medical Education

Murray A, Linn SM, Yu B, Novitzky-Basso I, et al. Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease. Bone Marrow Transplant 2024 Feb 24. doi: 10.1038/s41409-024-02249.
PMID: 38402344